What does 'breakthrough' mean to docs and consumers? It's not the FDA definition
20 April 2016
According to the dictionary, the word breakthrough means “a sudden, dramatic and important discovery or development.” However, what many doctors don’t know is that it doesn’t have the same meaning in the FDA drug approval process.
IMS Institute Report Examines Medicine Use and Spending in 2015
20 April 2016
The IMS Institute for Healthcare Informatics released its annual Medicines Use and Spending in the U.S. report, a review of 2015 and outlook to 2020 of the medicines market. The report, officially released on April 14, 2016, analyzed medicine use in the United States, focusing specifically on spending, drivers of growth, major market segments, prescription volume, patient costs, and healthcare delivery changes.
Pharma-backed initiative delivers low-cost hep C drugs
20 April 2016
A new program run by charities and academia with the support of pharma is looking to cure 25,000 hep C patients in Africa and Southeast Asia by allowing better access to new drugs.
New imaging technique shows whether drugs work in cancer patients
20 April 2016
The first cancer patient in Europe has been scanned with a revolutionary imaging technique that could enable doctors to see whether a drug is working within a day or two of starting treatment.
19 April 2016
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, presented preclinical data of ganaxolone IV, the Company’s intravenous formulation of its CNS-selective GABAA modulator, showing robust activity in a well-accepted and clinically translatable animal model of status epilepticus (SE). The data were presented during an oral and poster presentations at the 68th American Academy of Neurology (AAN) Annual Meeting in Vancouver, BC, Canada, April 15-21, 2016.
Report: Med tech venture rounds upsized but more sparse in Q1
19 April 2016
Two of the three largest venture rounds in U.S. life science startups last quarter went to medical device companies. That's a bit of an unusual state of affairs for med tech--which sometimes has the reputation of getting investment in dribs and drabs to back tech that's none too innovative.
Q1 '16: Venture cash is still pouring into U.S. biotechs
19 April 2016
Even as share prices and biotech valuations wilted under the glare of a savage bear market during the first quarter of the year, venture capital groups showed no signs of slowing down from last year’s torrid pace. A roundup of U.S. venture activity concluded that VCs invested $1.8 billion in biotech companies--just a rounding error short of the $1.81 billion total tracked for the same period a year ago.
World’s older population grows dramatically
19 April 2016
The world’s older population continues to grow at an unprecedented rate. Today, 8.5 percent of people worldwide (617 million) are aged 65 and over. According to a new report, “An Aging World: 2015(link is external),” this percentage is projected to jump to nearly 17 percent of the world’s population by 2050 (1.6 billion).
Siberian silver to fight viruses, bacteria and fungi
19 April 2016
Researchers at Tomsk Polytechnic (TPU), a leading university in Siberia, are developing a silver nanoparticles based medicinal solution called “Argovit,” which is believed to be equally effective against viruses, germs, and fungi.
FDA urges companies to get on board with continuous manufacturing
18 April 2016
A handful of companies have done pioneering work with continuous manufacturing, the production process that is faster, cheaper and less prone to the kinds of manufacturing mess-ups that worry the FDA. Now that the FDA has for the first time approved a company switching production of a drug from batch to continuous manufacturing, the agency is inviting others to get on board with the process.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023